Forest, Lundbeck Lose Bid To Limit Lexapro Claims

Law360, New York (July 1, 2009, 12:00 AM EDT) -- A federal judge has rejected the latest bid from H. Lundbeck A/S and its partner Forest Laboratories Inc. to pare down a patent dispute related to the antidepressant citalopram, ruling that a lone letter from one of the companies' suppliers did not yield enough evidence to drop part of Infosint SA's infringement claims.

Judge Lewis A. Kaplan of the U.S. District Court for the Southern District of New York refused to dismiss Infosint's claim that a compound called 5-carboxyphthalide, an intermediate chemical created while making citalopram,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.